SNPHY OTC
Santen Pharmaceutical Co., Ltd.
1W: -3.4%
1M: -6.1%
3M: -24.1%
YTD: -1.9%
1Y: -1.7%
3Y: +18.1%
5Y: -22.5%
$10.55
-0.57 (-5.13%)
Weekly Expected Move ±6.1%
$9
$10
$11
$11
$12
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$296B
Revenue
-1.5% YoY
$38B
Net Income
+4.6% YoY
$32B
Free Cash Flow
-41.3% YoY
61.4%
Gross Margin
21.1%
Op. Margin
19.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE13.0%
ROA9.1%
ROIC14.6%
Valuation
P/E13.8
P/B1.8
EV/EBITDA0.0
Leverage
Debt/Equity0.12
Current Ratio2.60
Interest Cov.33.6x
Quality Scores
Piotroski F7/9
Altman Z—
Beneish M-2.47